Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|May 1, 2021
Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axisMartin Böttcher, Heiko Bruns, Simon Völkl, et al.Nature Reviews. Rheumatology|August 6, 2024
Advancements and challenges in CAR T cell therapy in autoimmune diseasesGeorg Schett, Fabian Müller, Jule Taubmann, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2015
Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism of myeloid-derived suppressor cell induction operating in human hepatic stellate cellsYazid J Resheq, Ka-Kit Li, Stephen T Ward, et al.Journal for Immunotherapy of Cancer|March 10, 2023
Accumulation of T-cell-suppressive PD-L1<sup>high</sup> extracellular vesicles is associated with GvHD and might impact GvL efficacyRebecca Baur, Franziska Karl, Romy Böttcher-Loschinski, et al.Cell Communication and Signaling : CCS|April 11, 2025
A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemiaValeria Bica, Veronica Venafra, Giorgia Massacci, et al.Scientific Reports|May 23, 2020
PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone massDorothea I H Müller, Cornelia Stoll, Katrin Palumbo-Zerr, et al.Med (New York, N.Y.)|July 24, 2025
Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitisTobias Hegelmaier, Denise Wolleschak, Vaia Pappa, et al.Hemasphere|March 4, 2024
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockadeDenis M Schewe, Fotini Vogiatzi, Ira A Münnich, et al.Molecular Oncology|September 24, 2025
Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivityMarco Strecker, Keren Zohar, Martin Böttcher, et al.European Journal of Haematology|January 2, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patientsVanja Zeremski, Louisa Adolph, Sina Beer, et al.Pageof 16